10-Year Survival for Child-Pugh Class A Cirrhosis
Patients with compensated Child-Pugh class A cirrhosis have a median survival exceeding 12 years, with approximately 47% surviving to 10 years after diagnosis.
Survival Data
The prognosis for Child-Pugh class A cirrhosis is substantially better than decompensated disease, though still carries significant long-term mortality risk:
- Median survival in compensated cirrhosis exceeds 12 years, compared to only 1.8 years once decompensation occurs 1
- 10-year survival probability is approximately 47% based on historical cohort data of compensated cirrhosis patients 2
- 10-year probability of developing decompensation is 58%, which dramatically worsens prognosis once it occurs 2
Key Prognostic Factors Within Class A Cirrhosis
Not all Child-Pugh class A patients have identical outcomes. Several factors predict which compensated patients will fare worse:
- Serum bilirubin level (most important predictor) 2
- Prothrombin time prolongation 2
- Serum gamma-globulin concentration 2
- Presence of hepatic stigmata 2
- Age and sex 2
- Alkaline phosphatase level 2
Portal Hypertension Substaging
Modern risk stratification goes beyond Child-Pugh classification alone. Compensated cirrhosis should be further substaged based on portal hypertension severity 1:
- Clinically significant portal hypertension (CSPH), defined as hepatic venous pressure gradient ≥10 mm Hg, is present in 50-60% of compensated cirrhosis patients 1
- CSPH increases risk of developing varices, decompensation (ascites, variceal hemorrhage, hepatic encephalopathy), and hepatocellular carcinoma 1
- Patients with gastroesophageal varices have CSPH by definition and worse prognosis 1
Clinical Implications
The critical goal is preventing decompensation, as this represents the major inflection point where survival drops precipitously from years to months 1. While Child-Pugh class A patients are generally compensated, approximately 42% already have gastroesophageal varices at diagnosis, indicating more advanced portal hypertension 1.
Common pitfall: Assuming all Child-Pugh class A patients have uniformly excellent prognosis. The 47% 10-year survival means over half will die within a decade, emphasizing the need for aggressive management of underlying liver disease, surveillance for hepatocellular carcinoma, and prevention of decompensating events 2.